Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysis (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2352-3018(22)00237-5
PubMed Identifier: 36332652
Publication URI: http://europepmc.org/abstract/MED/36332652
Type: Journal Article/Review
Parent Publication: The Lancet HIV
Issue: 11
ISSN: 2352-3018